share_log

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Benzinga ·  Dec 27, 2024 05:05

Gainers

  • Coeptis Therapeutics (NASDAQ:COEP) shares rose 118.1% to $0.31 during Thursday's pre-market session. The market value of their outstanding shares is at $12.7 million.
  • Adagio Medical Holdings (NASDAQ:ADGM) stock moved upwards by 24.67% to $1.21. The market value of their outstanding shares is at $17.5 million.
  • China SXT Pharmaceuticals (NASDAQ:SXTC) shares rose 23.07% to $0.48. The company's market cap stands at $1.9 million.
  • TScan Therapeutics (NASDAQ:TCRX) stock rose 15.46% to $3.36. The market value of their outstanding shares is at $179.3 million.
  • RAPT Therapeutics (NASDAQ:RAPT) stock increased by 12.71% to $1.95. The market value of their outstanding shares is at $68.1 million.
  • Revelation Biosciences (NASDAQ:REVB) stock rose 12.64% to $0.34. The company's market cap stands at $2.8 million.

Losers

  • Anebulo Pharmaceuticals (NASDAQ:ANEB) stock fell 23.5% to $1.24 during Thursday's pre-market session. The market value of their outstanding shares is at $50.9 million.
  • Tivic Health Systems (NASDAQ:TIVC) stock declined by 18.23% to $0.3. The company's market cap stands at $2.5 million.
  • 180 Life Sciences (NASDAQ:ATNF) stock decreased by 16.56% to $2.42. The company's market cap stands at $4.7 million.
  • Carmell (NASDAQ:CTCX) stock decreased by 15.71% to $0.24. The company's market cap stands at $5.0 million.
  • Theriva Biologics (AMEX:TOVX) shares fell 14.78% to $1.5. The company's market cap stands at $4.1 million.
  • NeuroPace (NASDAQ:NPCE) stock decreased by 10.6% to $9.96. The company's market cap stands at $297.2 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment